Showing 107 of 107on this page. Filters & sort apply to loaded results; URL updates for sharing.107 of 107 on this page
Delcath Systems | LinkedIn
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial ...
Delcath Systems - Crunchbase Company Profile & Funding
Delcath Systems Announces U.S. Launch and First Commercial Treatment ...
Delcath Systems Corporate Presentation - (OTCQB: DCTH) January 2020 ...
Petition · Help Delcath Systems and cut the Boards Salaries! - United ...
DCTH - Delcath Systems | Fundamentei
Delcath Systems Is Prepared For A U.S. Commercial Launch (NASDAQ:DCTH ...
Delcath Systems Inc - Table of Contents Forward-Looking Statement 3 ...
Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma ...
Delcath Systems IB 12-10-07 | PDF
Delcath Systems to Participate in Investor Conferences, Focus on Liver ...
Delcath Systems announces updated results from CHOPIN phase 1b trial
David Hoffman Joins Delcath Systems as General Counsel and Corporate ...
Delcath Systems Secures $35M Following FDA Approval of HEPZATO KIT ...
Delcath systems Inc(NASDAQ: DCTH) : 네이버 블로그
Delcath Systems (DCTH) Announces Relisting On OTCQB - Cardiac Vascular News
Delcath Systems (NASDAQ:DCTH) and ChronoScale Corporation Common Stock ...
Delcath Systems Inc. - AnnualReports.co.uk
Bio-Path Holdings vs Delcath Systems | Comparably
Delcath Systems Raises $16.3M Through Warrant Exercise to Advance ...
Delcath Systems | Grafa
H.C. Wainwright Remains Bullish on Delcath Systems (DCTH)
Delcath Systems Reveals Release of Expert Review on Percutaneous ...
Delcath Systems | The Org
B2i Digital on LinkedIn: We want to welcome Delcath Systems to the ROTH ...
Delcath Systems 2
Delcath Systems Highlights Two ASCO 2026
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results ...
Delcath Systems (NASDAQ:DCTH) Skyrockets on FDA Approval for Hepzato ...
Delcath Systems 2026 Company Profile: Stock Performance & Earnings ...
Delcath Systems announces US FDA acceptance of Hepzato Kit NDA resubmission
Delcath Systems Introduces Healthcare Setting Locator for Hepzato Kit ...
Delcath Systems Closes Financing and Appoints Dr. Martha Rook as COO ...
MassDevice Q&A: Delcath CEO Eamonn Hobbs - MassDevice
Delcath registers $100m offering - MassDevice
Prospective Clinical and Pharmacological Evaluation of the Delcath ...
Our Therapy - Delcath
Diagram of the percutaneous hepatic perfusion system. This Delcath ...
FDA approved Delcath Systems' Hepzato Kit (melphalan/Hepatic Delivery ...
5 DELCATH SYSTEMS, INC
Delcath Systems, Inc is now enrolling patients at Moffitt Cancer Center ...
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - February 12, 2013
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - INVESTOR PRESENTATION ...
Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan ...
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - EXHIBIT 99.1 - ANNUAL ...
Delcath Systems, Inc (@DelcathSystems) / Posts / X
Careers - Delcath
Delcath Systems' CHOPIN Phase 2 Trial and Its Implications for Liver ...
(PDF) Evaluation of Delcath Systems' Generation 2 (GEN 2) Melphalan ...
DELCATH SYSTEMS, INC. - FORM 8-K - EX-99.1 - March 4, 2013
Delcath presents breast cancer liver data at ESMO | DCTH Stock News
Delcath receives regulatory approval for the Generation Two Hepatic ...
Delcath Systems, Inc. Announces Promising Results from Independent ...
Delcath Systems: Navigating European Hurdles to Capture Long-Term ...
Delcath Systems' Q3 2025 Financials and Strategic Momentum in Oncology
Cancer: Delcath lands expanded CE Mark for organ-isolating chemo ...
Delcath Systems: Filtering Through Its Past & Future - YouTube
生物制药公司：迪卡斯系统 Delcath Systems(DCTH) | 美股之家 - 港股美股开户投资百科全书
Delcath - Interventional News
Delcath EMEA | LinkedIn
Martha S. Rook Named COO of Delcath Systems, Inc., Oncology Leader ...
Delcath doses first patient in Phase 2 HEPZATO trial | DCTH Stock News
Delcath Systems: Riding the HEPZATO Wave, But Can the Surge Last?
Gerard Michel Net Worth, Biography, and Insider Trading
Percutaneous melphalan perfusion can induce significant responses in ...
Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market ...
An Anesthesia-Specific Protocol for Percutaneous Hepatic Perfusion (PHP ...
7
secure
Slide 4
#oog #chemosat #delcath #liverdirectedtherapy #uvealmelanoma # ...
FDA approval of Hepzato Kit for the treatment of adult patients with ...
Delcath's 2025 Growth Trajectory and HEPZATO Momentum: Strategic ...
First patient in Texas receives new treatment for metastatic uveal ...
Trial data muddy Delcath's path to approval for liver tumor device
#patientcare #innovation #hepzatokit #delcath #php # ...
100 Stock Ideas Heading Into 2026
(PDF) Extrakorporale Perfusion mit dem Delcath-System: Methodik der ...
Bioidea Group
(PDF) Safety of Percutaneous Hepatic Perfusion with Melphalan in ...
Initiation of Chemosaturation With Percutaneous Hepatic Perfusion ...
HEPZATO KIT - Melphalan Hydrochloride for Injection/Hepatic ...
Erratum to: Prospective Clinical and Pharmacological Evaluation of the ...
【即時新聞】Delcath Systems公佈FOCUS研究子群分析結果，揭示治療潛力 | CMoney投資網誌
FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma ...
6
HEPZATO KIT™ Access
